Published in Biotech Business Week, November 24th, 2003
Altiva is an early stage company building a solid asset portfolio through the acquisition of existing spinal products and systems as well as acquiring broad distribution rights to other existing spinal technologies. The intent of this strategic investment is to provide entry for Exactech into the growing spinal products market.
Altiva recently acquired a degenerative plate and screw system, a proprietary machined allograft bone design, a strategic partnership for allograft bone and certain patents for a unique rod based low back system. The company is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.